Australia Stock Exchange release from BCAL DIAGNOSTICS : Dr John Hurrell Appointed Chief Executive Officer
10/01/2022 21:21
Australia Stock Exchange release from BCAL DIAGNOSTICS BDX.AX : Dr John Hurrell Appointed Chief Executive Officer
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures